HSPA5 and liver cancer: Hong et al. revealed that exosomes generated from bone marrow-derived MSCs could convey siRNA-GRP78 to recipient liver cancer cells and inhibit the expression of GRP78 so as to enhance the sensitivity of cancer cells to sorafenib (Li H. et al., 2018).